• Institute: Department of Medical Microbiology and Hygiene of University of Regensburg (Regensburg, Germany)
  Planned duration: 2003 - 2009
  Leader: Dr. med. habil. János Minárovits D.Sc., Head of Department
  Topic: They have reviewed data on the relation of Epstein-Barr virus and auto-immune diseases.
• Institute: University Hospital for Infectious Diseases, (Zagreb, Croatia).
  Planned duration: 2007-2009
  Leader: Mária Mezei, Microbiologist, Katalin Balogh, Microbiologist
  Topic: They have continued the genetic analysis of subtypes of strains HIV-1 carried by HIV infected persons and AIDS patients in Croatia.

(2) 2nd Department of Bacteriology

• Institute: Netherlands Vaccine Institute (Netherlands), Health Protection Agency (London, United Kingdom), Norwegian Institute of Public Health (Oslo, Norway), Swedish Institute for Infectious Disease Control (Stockholm, Sweden), Statens Serum Institute (Copenhagen, Denmark), Paul Ehrlich Institute (Germany), Novartis S.r.I. (Italy), Institutio de Biologica Experimental Technologica (Lisbon, Portugal), National Institute of Public Health (Warsaw, Poland).
  Planned duration: 2008 - 2009
  Leader: Dr. Mária Herpay, Head of Department
  Topic: Laboratory diagnostics of dangerous pathogenic bacteria, participation in preparation of measures for treatment of patients and control of spread of infections. Stressed pathogenic bacteria: Bacillus anthracis, Vibrio cholerae, Yersinia spp., Shigella spp., EHEC (STEC/VTEC), Shiga toxins, cholera enterotoxin.
• Institute: Swedish Institute for Infectious Disease Control (Solna, Sweden); Oesterreichische Agentur fuer Gesundheit und Ernaehrungssicherheit GmbH, Austrian Agency for Health and Food Safety AGES (Vienna, Austria), Centrum Voor Onderzoek in Diergeneesskunde en Agrochemie Centre (Brussel, Belgium), Friedrich-Loeffler Institut, Federal Research Institute for Animal Health (Insel Riems Greiswald, Germany), Istituto Superiore di Sanité (Rome, Italy), Health Protection Agency (Porton Down, England), National Institute for Health Welfare (Helsinki, Finland), National and Kapodistrian University of Athen (Athen, Greece), National Public Health Surveillance Laboratory (Vilnius, Lithuania), Norwegian Institute of Public Health (Oslo, Norway), National Institute of Hygiene (Warsaw, Poland), Basque Foundation for Health Innovation and Research, (Sondika, Spain), National Institute for Public Health and Enviroment (Bilthoven, Netherlands), Intituto Zooprofilattico Sperimentale della Puglia e della Basilicata (Foggia, Italy) National Center of Infectious and Parasitic Diseases (Sofia, Bulgaria)
  Planned duration: 2008 - 2010
  Leader: Dr. Mária Herpay, Head of Department
  Topic: Diagnostics of dangerous pathogenic bacteria (Bacillus anthracis, Francisella spp., Brucella spp., Yersinia pestis, Burkholderia mallei, B. pseudomallei, Coxiella burnetii)

(3) Department of Parasitology

• Institute: Servicio de Parasitologia Centro Nacional de Microbiologia Instituto de Salud Carlos III (Madrid, Spain)
  Planned duration: 2005 - continuous
  Leader: Dr. István Kucsera, Acting Head of Department
  Topic: Zoonotic protozoons (Toxoplasma gondii, Giardia duodenali) and their human and animal incidence; molecular biological and immunological featuring with a priority of laboratory diagnostic and epidemiological aspects. Molecular biological characterization of malaria.
  See detailed description in topics III.2.1. and III.2.2.
• Institute: Medical University, Department of Medical Parasitology, Institute of Specific Prophylaxis and Tropical medicine (Vienna, Austria)
  Planned duration: 2009 - 2010
  Leader: Dr.István Kucsera, Head of Department
  Topic: Incidence of zoonotic nematode Dirofilaria repens in humans and animals and the biological, immunological and morphological characterisation of the worm with a focus on laboratory diagnostic and epidemiological aspects.
  Detailed description in topic III.2.4.

(4) Department for QC of Viral Vaccines

Institute: Scientific Institute of Public Health (Brussels, Belgium)
Planned duration: continuous
Leader: Dr. Zsuzsanna Pauliny, Head of Department
Topic: Within the frame of the collaboration agreement the Belgian authority performs the tests being under validation at the Department.

(5) Department for QC of Bacterial Vaccines

International coordinating institute: WHO Access to Technologies (ATT), Vaccines and Biologicals (Geneva, Switzerland)
Planned duration: continuous
Coordinators of NCE: Dr. Zsuzsanna Békési, Head of Department
Topic: Based on the contract between NCE and WHO, the tetanus efficiency of vaccines with various compositions was determined, and they participated at the annual meeting of EU EDQM responsible for drug quality (Vienna, Austria).

Summary of the activities of the National Center for Epidemiology in 2010

International relations

National Centres established in NCE and participating in international programmes

Participation in international working committees